ISG15 and hepatocellular carcinoma: Many studies have confirmed that dysregulation of ISG15 and its conjugated compounds is found in many primary cancers, such as breast10,26–28, prostate29 and bladder cancers30, hepatocellular carcinoma (HCC) and oral squamous cell carcinoma31.